Prostate Corpuscles: Looking for Biomarkers of Early Prostate Cancer
Prostate cancer is the second most diagnosed disease in men in the world, and the mortality rate has been rising in recent years. At present, there are two early screening tests which are determination of plasma concentration of prostate specific antigen and prostate rectal contact. However, these tests do not have the best specificity and sensitivity for the detection. Although different studies have searched for new biomarkers through the implementation of new generation sequencing, mass spectrometry and other technologies, the same shortcomings still exist, so they cannot be translated in clinical practice; Therefore, the discovery of new prostate cancer biomarkers is a challenge for the scientific community.
Prostate corpuscles correspond to extracellular vesicles secreted by normal prostate or tumor tissues and can be detected in different liquids. Structurally, prostate bodies are different from other exosomes because their size, membrane composition and specific protein content make them a potential and new source of clinical biomarkers.
In this regard, this review reviews protein biomarkers isolated from prostaglandin glands present in different biological fluids for potential diagnosis of prostate cancer. To this end, a systematic search was conducted on PubMed for proteomic studies of prostate cancer, including extracellular vesicles, exosomes and prostaglandin glands, as well as blood, urine, semen and other biological samples.
Pullar B, Shah N, 2016, Prostate Cancer. Surg, 34:505–11.
Ferlay J, Soerjomataram I, Ervik M, et al., 2012, GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0. International Agency for Research on Cancer. Available from: http://publications.iarc.fr/Databases/Iarc-Cancer bases/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1.0-2012.
OPS, 2017, Inter American Health Information Platform. Available from: https://www.paho.org/hq/index.php? option=com_tabs&view=article&id=2151&itemid=36 32⟨=en.
Lima AR, Lourdes BM, Carvalho M, et al., 2016, Biomarker Discovery in Human Prostate Cancer: An Update in Metabolomics Studies. Transl Oncol, 9:357–70.
Goo YA, Goodlett DR, 2010, Advances in Proteomic Prostate Cancer Biomarker Discovery. J Proteomics, 73:1839–50.
Castillejos-Molina RA, Gabilondo-Navarro FB, 2016, Prostate Cancer. Salud Publica Mex, 58:279–84.
National Cancer Institute, Prostate Specific Antigen (PSA) Analysis. Available from: https://www.cancer.gov/es panol/tipos/prostata/sheet-information-psa.
Heidenreich A, Bellmunt J, Bolla M, et al., 2011, EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease. Eur Urol, 59:61–71.
Loeb S, Catalona WJ, 2014, The Prostate Health Index: A New Test for the Detection of Prostate Cancer. Ther Adv Urol, 6:74–7.
Lazzeri M, Abratea A, Lughezzani G, et al., 2014, Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination. Urology, 83:606–12.
Hessels D, Gunnewiekd JMTK, Oort I, et al., 2003, DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer. Eur Urol, 44:8–16.
Fradet F, Saadb F, Aprikian A, et al., 2004, uPM3, A New Molecular Urine Test for the Detection of Prostate Cancer. Urology, 64:311–5.
Wang R, Chinnaiyan AM, Dunn RL, et al., 2009, Rational Approach to Implementation of Prostate Cancer Antigen 3 into Clinical Care. Cancer, 115:3879–86.
Álvarez-Blanco MA, Escudero-de los Ríos PM, Hernández-Toríz N, 2008, Cáncer de próstata [Prostate Cancer]. Rev Mex Urol, 68:245–54.
Aalberts M, Stout TAE, Stoorvogel W, 2014, Prostasomes: Extracellular Vesicles from the Prostate. Reproduction, 147:R1–R14.
Nilsson J, Skog J, Nordstrand A, et al., 2009, Prostate Cancer-Derived Urine Exosomes: A Novel Approach to Biomarkers for Prostate Cancer. Br J Cancer, 100:1603–7.
Zijlstra C, Stoorvogel W, 2016, Prostasomes as a Source of Diagnostic Biomarkers for Prostate Cancer. J Clin Invest, 126:1144–51.
Saez F, Sullivan R, 2016, Prostasomes, Post-Testicular Sperm Maturation and Fertility. Front Biosci, 21:1464–73.
Ronquist G, 2012, Prostasomes are Mediators of Intercellular Communication: From Basic Research to Clinical Implications. J Intern Med, 271:400–13.
Utleg AG, Yi EC, Xie T, et al., 2003, Proteomic Analysis of Human Prostasomes. Prostate, 56:150–61.
Ronquist KG, Ronquist G, Larsson A, et al., 2010, Proteomic Analysis of Prostate Cancer Metastasis-Derived Prostasomes. Anticancer Res, 30:285–90.
Melo SA, Luecke LB, Kahlert C, et al., 2015, Glypican-1 Identifies Cancer Exosomes and Detects Early Pancreatic Cancer. Nature, 523:177–82.
Tavoosidana G, Ronquist G, Darmanis S, et al., 2011, Multiple Recognition Assay Reveals Prostasomes as Promising Plasma Biomarkers for Prostate Cancer. Proc Natl Acad Sci, 108:8809–14.
Sartori DA, Chan DW, 2014, Biomarkers in Prostate Cancer. Curr Opin Oncol, 26:259–64.
Nilsson BO, Carlsson L, Larsson A, et al., 2001, Autoantibodies to Prostasomes as New Markers for Prostate Cancer. Ups J Med Sci, 106:43–50.
Fredriksson S, Gullberg M, Jarvius J, et al., Protein Detection Using Proximity-Dependent DNA Ligation Assays. Nat Biotechnol, 20:473–7.
Gu J, Ren L, Wang X, et al., 2015, Expression of Livin, Survivin and Caspase-3 in Prostatic Cancer and Their Clinical Significance. Int J Clin Exp Pathol, 8:14034–9.
Khan S, Simpson J, Lynch LC, et al., 2017, Racial Differences in the Expression of Inhibitors of Apoptosis (IAP) Proteins in Extracellular Vesicles (EV) from Prostate Cancer Patients. PLoS One, 12:e0183122.
Khan S, Jutzy JMS, Aspe JR, et al., 2011, Survivin is Released from Cancer Cells via Exosomes. Apoptosis, 16:1–12.
Khan S, Jutzy JMS, Valenzuela MMA, et al., 2012, Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer. PLoS One, 7:e46737.
Gabriel K, Ingram A, Austin R, et al., 2013, Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer. PLoS One, 8:e70047.
Huang X, Yuan T, Liang M, et al., 2015, Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer. Eur Urol, 67:33–41.
Bryant RJ, Pawlowski T, Catto JWF, et al., 2012, Changes in Circulating microRNA Levels Associated with Prostate Cancer. Br J Cancer, 106:768–74.
Filipazzi P, Bürdek M, Villa A, et al., 2012, Recent Advances on the Role of Tumor Exosomes in Immunosuppression and Disease Progression. Semin Cancer Biol, 22:342–9.
Lundholm M, Schröder M, Nagaeva O, et al., 2014, Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion. PLoS One, 9:e108925.
Gámez-Valero A, Lozano-Ramos S, Bancu I, et al., 2015, Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases former. Front Immunol, 6:6.
Principe S, Jones EE, Kim Y, et al., 2013, In-Depth Proteomic Analyses of Exosomes Isolated from Expressed Prostatic Secretions in Urine. Proteomics, 13:1667–71.
Skog JKO, Breakefield XO, Brown D, et al., 2013, Uso de Microvesículas en el Diagnóstico, Pronóstico y Tratamiento de Enfermedades y Afecciones Médicas [Application of Microbubbles in Diagnosis, Prognosis and Treatment of Diseases and Medical Conditions]. Boston, USA 2446301.
Øverbye A, Skotland T, Koehler CJ, et al., 2015, Identification of Prostate Cancer Biomarkers in Urinary Exosomes. Oncotarget, 6:30357–76.
Cotton RW, Fisher MB, 2015, Review: Properties of Sperm and Seminal Fluid, Informed by Research on Reproduction and Contraception. Forensic Sci Int Genet, 18:66–77.
Roberts MJ, Richards RS, Gardiner RA, et al., 2015, Seminal Fluid: A Useful Source of Prostate Cancer Biomarkers? Biomark Med, 9:77–80.
Lo Cicero A, Stahl PD, Raposo G, 2015, Extracellular Vesicles Shuffling Intercellular Messages: For Good or for Bad. Curr Opin Cell Biol, 35:69–77.
Carlsson L, Nilsson O, Larsson A, et al., 2003, Characteristics of Human Prostate Isolated from Three Different Sources. Prostate, 54:322–30.
Kovak MR, Saraswati S, Goddard SD, et al., 2013, Proteomic Identification of Galectin-3 Binding Ligands and Characterization of Galectin-3 Proteolytic Cleavage in Human Prostasomes. Andrology, 1:682–91.
Block AS, Saraswati S, Lichti CF, et al., 2011, Copurification of Mac-2 Binding Protein with Galectin-3 and Association with Prostasomes in Human Semen. Prostate, 71:711–21.
Roberts MJ, Chow CWK, Schirra HJ, et al., 2015, Diagnostic Performance of Expression of PCA3, Hepsin and miR Biomarkers Inejaculate in Combination with Serum PSA for the Detection of Prostate Cancer. Prostate, 75:539–49.
Dubois L, Stridsberg M, Kharaziha P, et al., Malignant Cell-Derived Extracellular Vesicles Express Different Chromogranin Epitopes Compared to Prostasomes. Prostate, 75:1063–73.
Babiker AA, Ronquist G, Nilsson B, et al., 2006, Overexpression of Ectoprotein Kinases in Prostasomes of Metastatic Cell Origin. Prostate, 66:675–86.
Teixeira JH, Silva AM, Almeida MI, et al., 2016, Circulating Extracellular Vesicles: Their Role in Tissue Repair and Regeneration. Transfus Apher Sci, 55:53–61.
Tosoian JJ, Carter HB, Lepor A, et al., 2016, Active Surveillance for Prostate Cancer: Current Evidence and Contemporary State of Practice. Nat Rev Urol, 13:205–15.
Basourakos SP, Davis JW, Chapin BF, et al., 2018, Baseline and Longitudinal Plasma Caveolin-1 Level as a Biomarker in Active Surveillance for Early Stage Prostate Cancer. BJU Int, 121:69–76.
Pellinen T, Blom S, Sánchez S, et al., 2018, ITGB1-Dependent Upregulation of Caveolin-1 switches TGFβ Signalling from Tumour-Suppressive to Oncogenic in Prostate Cancer. Sci Rep, 8:2338.
Gimenez-Bonafe P, Mir R, Martínez-Soler F, et al., 2014, Multidrug Resistance Protein 1 Localization in Lipid Raft Domains and Prostasomes in Prostate Cancer Cell Lines. Onco Targets Ther, 7:2215–25.
Renzulli JF, Del Tatto M, Dooner G, 2010, et al., Microvesicle Induction of Prostate Specific Gene Expression in Normal Human Bone Marrow Cells. J Urol, 184:2165–71.